Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 339 results found. Search for [ COVID-19 vaccine SII ]

Results 1 to 21 of 339
PTI
April 9, 2021
Citing officials, Geo News reported that the Drug Regulatory Authority of Pakistan (DRAP) has granted Emergency Use Authorization (EUA) to another Chinese vaccine, CoronaVac


Reuters
April 9, 2021
\"The agreement is legally binding and served as a basis for the first-round allocation document, which has been communicated to all participating economies,\" a Gavi spokeswoman said in an email


PTI
April 9, 2021
Despite increased demand for COVID-19 vaccines in India COVAX expects to deliver doses to all participating economies that have requested vaccines in the first half of the year


Reuters
April 9, 2021
The international community should work together to resist 'vaccine nationalism,' strengthen cooperation and policy coordination to fight against COVID-19, and improve the accessibility and affordability of vaccines in developing countries in a meaningful way, Yi Gang, Governor of the People's Bank of China said


BusinessToday.In
April 9, 2021
The move by the national committee on adverse effects following immunisation (AEFI) has come after the European's regulator said it found rare cases of blood clots among some adult recipients who were given AstraZeneca-Oxford university's vaccine shots


PTI
April 9, 2021
A growing number of countries have either halted or limited the use of the AstraZeneca coronavirus vaccine recently over fears that it can cause serious blood clots


PTI
April 9, 2021
Treasury has confirmed that the Serum Institute of India has fully refunded us for the remaining 500,000 doses that had not been delivered to South Africa and the money is already in our bank account, Health Minister Zweli Mkhize said


Reuters
April 9, 2021
The Philippines suspended the use of AstraZeneca shots for people under age 60 after Europe's regulator said on Wednesday it found rare cases of blood clots among some adult recipients, although it still believes that the vaccine's benefits outweighed its risks


BusinessToday.In
April 8, 2021
Adar Poonawalla said that SII has submitted a formal proposal for an upfront grant from the government. It is otherwise difficult to ramp up as they have already poured in thousands of crores and borrowed Rs 1,500 crore, he said


BusinessToday.In
New Delhi, April 8, 2021
Serum Institute of India CEO Adar Poonawalla on Tuesday said that the effectiveness of the Covishield vaccine rises to as much as 90 per cent if the two shots are separated by about 2.5-3 months. Speaking to India Today, Poonawalla added that no COVID-19 vaccine is preventing more than 20-30 per cent of recipients from getting the disease. He said that the vaccine acts as a shield, which prevents anyone from going to the hospital and the same applies to different virus mutations. He also said that immunity kicks in one month after taking the first dose of the Covishield vaccine. Watch the video for more.Watch More | Is Covishield safe for people with low immunity? CEO of SII replies


BusinessToday.In
April 8, 2021
Vardhan says as long as supply of vaccines remains limited, there is no option but to prioritise. Maharashtra has vaccinated only 86 per cent of health workers with first dose; just 41 per cent healthcare workers with the second dose, he adds


BusinessToday.In
New Delhi, April 7, 2021
CEO of Serum Institute of India Adar Poonawalla spoke to India Today about when the vaccination can be opened up for all. He stated that it was a difficult decision even for the government as the priority was to protect the most vulnerable people and keeping that in mind, vaccinating everyone immediately was not an option. He also shared that for the moment SII had stopped exporting vaccines considering the second wave of the virus that had gripped the nation. Indians were a priority at this hour, he added. Watch the video for more.Also Read: Centre allows COVID-19 vaccination drives at workplaces from April 11


BusinessToday.In
April 7, 2021
Rajesh Tope said that the state currently has 14 lakh COVID-19 vaccine doses, which will get consumed in three days. He said that Maharashtra has asked for 40 lakh additional doses


BusinessToday.In
April 7, 2021
\"We need roughly Rs 3,000 crore which is not a small figure considering we have already spent thousands of crores,\" said Adar Poonawalla


Associated Press
April 7, 2021
SII CEO Adar Poonawalla said the company has \"chosen to prioritize India temporarily for two months\" and hopes to then restart exports by June


BusinessToday.In
April 6, 2021
Adar says Covishield has found an excellent response below the age of 50 with one dose. About 70 per cent of people are fully protected with one dose, but the second dose is necessary for long-term immunity protection, he adds


PTI
April 6, 2021
I've had substantial contact with the Serum Institute. India is blessed with having a major manufacturer of global vaccines in India, World Bank President David Malpass said


BusinessToday.In
April 1, 2021
The refusal to grant the certification means that the export of Covaxin to the country would face a delay. It must be mentioned here that a GMP certification is necessary in Brazil for companies looking to sell drugs or vaccines


BusinessToday.In
March 31, 2021
The Drug Controller General of India (DCGI) has allowed the extension of AstraZeneca coronavirus vaccine's expiration time period from the earlier prescribed six months


Reuters
March 30, 2021
After a slow start, India is picking up the pace of its immunisation campaign as it tries to head off a new surge in infections that has brought the highest tallies of daily cases and deaths in months


PAGES 1 OF 17  12345